T1	p 77 122	treated hypertensive patients . Collaborative
T2	p 275 323	hypertensive patients receiving drug treatment ,
T3	p 785 1085	people with one or more cardiovascular risk factors . Fifteen Italian hypertension units studied 142 hypertensive patients ( 76 men , 66 women ; mean age 59 +/- 5.9 years ) treated with different antihypertensive drugs : 71 patients were randomized to aspirin and 71 served as controls . All patients
T4	i 17 36	low-dose aspirin on
T5	i 48 58	ambulatory
T6	i 109 122	Collaborative
T7	i 144 162	Prevention Project
T8	i 195 230	Nonsteroidal antiinflammatory drugs
T9	i 360 367	aspirin
T10	i 443 474	doses of aspirin ( 100 mg/day )
T11	i 761 784	aspirin or vitamin E in
T12	i 981 1003	antihypertensive drugs
T13	i 1037 1058	aspirin and 71 served
T14	i 1062 1072	controls .
T15	i 1096 1207	a clinic BP evaluation with an automatic sphygmomanometer and a 24-h ambulatory BP monitoring , at baseline and
T16	i 1214 1215	3
T17	i 1223 1245	of aspirin treatment .
T18	i 1414 1421	aspirin
T19	i 1681 1688	aspirin
T20	i 1769 1779	inhibitors
T21	i 1784 1803	calcium antagonists
T22	i 1915 1922	aspirin
T23	o 44 73	and ambulatory blood pressure
T24	o 242 263	blood pressure ( BP )
T25	o 485 541	and ambulatory systolic ( SBP ) and diastolic ( DBP ) BP
T26	o 1105 1118	BP evaluation
T27	o 1165 1178	ambulatory BP
T28	o 1282 1303	in clinic SBP and DBP
T29	o 1373 1395	Ambulatory SBP and DBP
T30	o 1926 1936	BP control